Status:
COMPLETED
Early Integration of Supportive Care for Metastatic Uveal Melanoma Patients (EarlyTogether)
Lead Sponsor:
Institut Curie
Conditions:
Uveal Melanoma
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The study main objective is to assess whether the early introduction of supportive care demonstrates a benefit on patients' psychological care needs at 6 months (M6), versus oncological standard of ca...
Detailed Description
Before the start of the study, medical oncologists and supportive care physicians from both the sites will attend Communication Skills Training (CST) workshops provided by an expert team in the field....
Eligibility Criteria
Inclusion
- adult patients with metastatic UM;
- no surgery or loco-regional treatment of metastases in a curative intent;
- systemic treatment planned or started since less than 2 months;
- ECOG PS 0-1;
- no uncontrolled symptoms;
- liver function tests in normal range or ≤ grade 2;
- signed informed consent;
- able to fill the questionnaires.
Exclusion
- patient\<18 years old;
- patient condition requiring supportive care before any systemic specific treatment for metastases;
- acute psychopathological disorder incompatible with the study;
- prior medical condition incompatible with the study.
Key Trial Info
Start Date :
July 16 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 22 2025
Estimated Enrollment :
162 Patients enrolled
Trial Details
Trial ID
NCT04728113
Start Date
July 16 2020
End Date
January 22 2025
Last Update
September 8 2025
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Centre Antoine Lacassagne
Nice, France, 06189
2
Institut Curie
Paris, France, 75005